Corporate News     08-May-19
Vivimed Life Sciences recalls hypertensive drug from US market
On 08 May 2019
Vivimed Labs announced that its Board has decided to sell its stake in 50:50 JV with Strides for augmenting management focus on the growing FDF portfolio across India, RoW and CISmarkets and also to Improve financial flexibility for the domestic finished dosage business and reduction of long term leverage in the Indian operations. Consequently, VLL Sold balance 50% stake in Vivimed Life Sciences Private Limited, India to Strides Pharma Science Limited and the balance 50% stake in Strides Vivimed Pte Ltd, Singapore to Strides Pharma Global Pte, Singapore.
Previous News
  Vivimed Labs reports consolidated net loss of Rs 265.99 crore in the March 2023 quarter
 ( Results - Announcements 04-Jun-23   09:14 )
  Vivimed Labs consolidated net profit rises 26.50% in the June 2020 quarter
 ( Results - Announcements 31-Aug-20   08:18 )
  Lupin Ltd Slides 4.3%
 ( Hot Pursuit - 16-May-19   09:45 )
  Vivimed Labs to transfer subsidiary to Vivimed Specialty Chemicals UK
 ( Corporate News - 07-Sep-19   17:19 )
  Vivimed Labs Ltd Spikes 12.07%
 ( Hot Pursuit - 07-Feb-19   09:30 )
  Vivimed Labs to announce Quarterly Result
 ( Corporate News - 02-Aug-17   10:55 )
  Vivimed Labs gets healthier after subsidiary gets additional investment
 ( Hot Pursuit - 01-Jan-18   09:55 )
  Vivimed Labs reports consolidated net loss of Rs 23.68 crore in the December 2021 quarter
 ( Results - Announcements 15-Feb-22   08:18 )
  Vivimed secures additional investment of USD 7.5 mn in its overseas subsidiary
 ( Corporate News - 01-Jan-18   09:52 )
  Vivimed Labs to conduct board meeting
 ( Corporate News - 02-Aug-17   09:35 )
  Vivimead Labs
 ( Results - Analysis 17-Aug-11   12:05 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top